AAREY DRUGS & PHARMACEUTICALS
|
|
| BOM : 524412     NSE : AAREYDRUGS     | |
| LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Dec 11,2025 |
|
Price(EOD): ₹ 66.44
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 188.69 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AAREY DRUGS & PHARMACEUTICALS | -13.1% | -30.2% | 5.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.1% | 4.3% | -1.1% |
| DIVIS LABORATORIES | -0.6% | -1.3% | 5.6% |
| CIPLA | -0.6% | -0.5% | 1.4% |
| TORRENT PHARMACEUTICALS | 0.5% | -0.6% | 13.7% |
| DR REDDYS LABORATORIES | -0.2% | 3.6% | -0.3% |
| MANKIND PHARMA | -1.7% | -4.7% | -18.7% |
| ZYDUS LIFESCIENCES | -1% | -3% | -6% |
| LUPIN | -0.8% | 2.2% | -2.5% |
FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AAREY DRUGS & PHARMACEUTICALS
 | Ratio | Standalone | |
|---|---|---|
|
P/E P/B P/S |
52.56
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3.58 Cr
[Latest Qtr - Sep2025 - Standalone Results ] 1.39
P/B Calculated based on Book Value of Rs 135.97 Cr
[Latest Year - Mar2025 - Standalone Results ] 0.44
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2025 - Standalone Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
3453% 116% 127% |
SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS
AAREY DRUGS & PHARMACEUTICALS vs SENSEX
DEBT OF AAREY DRUGS & PHARMACEUTICALS
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.26 0.24 0.33 0.28 |
- - - - |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Sep2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS
| Standalone | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-17.66% 55.29% -14.18% -25.24% |
-19.96% -29.05% -15.06% -35.78% |
| QtrlyTrend |
-6 | |
| Latest Qtr: Sep2025 | ||
| Quarterly Result Analysis → | ||
AAREY DRUGS & PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about AAREY DRUGS & PHARMACEUTICALS
Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?
As on Dec 11,2025, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?
As on Dec 11,2025, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?
As on Dec 11,2025, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 29.30 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1.87
Fair Value [Median EV / Sales Model] : Rs. 30.70
Fair Value [Median Price / Sales Model] : Rs. 29.30
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 29.30
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.